3611
Late Breaking Oral Abstract Session: Clinical/Translational Science
Sunday, March 5, 2017: 2:00 PM-3:15 PM
Georgia World Congress Center, Building B, Level 2, Rooms B207-B208
Oral Session
1.25 CME/CE
Primary Moderators:
Steve N. Georas , MD
Roland Solensky , MD FAAAAI
2:00 PM
L6
TPSAB1 Genotype and Effects of Pro-Tryptases on Human Mast Cell-Associated Disorders
Jonathan Lyons, MD
2:15 PM
L7
Efficacy and Safety of Long-Term Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy with Viaskin® peanut: Results of the Two-Year Extension of the Vipes Phase IIb Clinical Trial
Wayne G. Shreffler, MD PhD FAAAAI
2:30 PM
L8
Evaluation of Risk Factors for Infections and Systemic Reactions (SRs) Associated with Subcutaneous and Sublingual Allergen Immunotherapy (SCIT and SLIT):  AAAAI/ACAAI National Surveillance Study 2008-2015
Tolly Epstein, MD MS FAAAAI
2:45 PM
L9
The Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicentre Evaluation
Jason A. Trubiano, MBBS, FRACP
3:00 PM
L10
Randomized Placebo-Controlled Multicenter Clinical Trial of Wheat Oral Immunotherapy
Anna H. Nowak-Wegrzyn, MD PhD FAAAAI